Imperva (NASDAQ:IMPV) was downgraded by research analysts at J P Morgan Chase & Co from a “neutral” rating to an “underweight” rating in a report issued on Tuesday.
Other equities research analysts also recently issued research reports about the company. Evercore ISI set a $56.00 target price on Imperva and gave the stock a “buy” rating in a report on Thursday, October 19th. Royal Bank of Canada reaffirmed a “buy” rating and set a $49.00 target price on shares of Imperva in a report on Wednesday, October 18th. Piper Jaffray Companies set a $58.00 target price on Imperva and gave the stock a “buy” rating in a report on Monday, August 28th. Oppenheimer reaffirmed a “buy” rating and set a $55.00 target price on shares of Imperva in a report on Thursday, November 9th. Finally, Zacks Investment Research downgraded Imperva from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 27th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $52.38.
Shares of Imperva (NASDAQ IMPV) opened at $41.85 on Tuesday. Imperva has a twelve month low of $35.80 and a twelve month high of $52.40.
A number of large investors have recently made changes to their positions in the business. Vanguard Group Inc. raised its stake in shares of Imperva by 4.3% during the 2nd quarter. Vanguard Group Inc. now owns 2,439,240 shares of the software maker’s stock worth $116,718,000 after buying an additional 99,799 shares during the period. BlackRock Inc. raised its stake in shares of Imperva by 11.3% during the 2nd quarter. BlackRock Inc. now owns 2,124,043 shares of the software maker’s stock worth $101,635,000 after buying an additional 215,170 shares during the period. Eagle Asset Management Inc. raised its stake in shares of Imperva by 1.2% during the 3rd quarter. Eagle Asset Management Inc. now owns 1,294,651 shares of the software maker’s stock worth $55,928,000 after buying an additional 14,803 shares during the period. Alyeska Investment Group L.P. raised its stake in shares of Imperva by 89.3% during the 3rd quarter. Alyeska Investment Group L.P. now owns 907,615 shares of the software maker’s stock worth $39,390,000 after buying an additional 428,163 shares during the period. Finally, ETF Managers Group LLC acquired a new position in shares of Imperva during the 2nd quarter worth approximately $41,888,000. 96.95% of the stock is owned by institutional investors.
ILLEGAL ACTIVITY NOTICE: “J P Morgan Chase & Co Lowers Imperva (IMPV) to Underweight” was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this article on another site, it was stolen and republished in violation of US and international trademark & copyright laws. The original version of this article can be read at https://sportsperspectives.com/2017/12/12/j-p-morgan-chase-co-lowers-imperva-impv-to-underweight.html.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc. and related companies with MarketBeat.com's FREE daily email newsletter.